Get started
Author

Magdalena Zawada

Observed names: M. Zawada, Magdalena Daria Zawada, Zawada, Magdalena
ORCID: 0000-0001-9105-1767
Observed ORCID: 0000-0001-9105-1767
OpenAlex ID: A5079195304
A comparison of qPCR and ddPCR used for quantification of the JAK2 V617F allele burden in Ph negative MPNs
2018 · Dorota Link-Lenczowska, Niels Pallisgaard, et al. · Annals of Hematology · 63
PDF
Cladribine added to daunorubicin-cytarabine induction prolongs survival of FLT3-ITD+ normal karyotype AML patients
2015 · Marta Libura, Sebastian Giebel, et al. · Blood · 40
PDF
Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study
2022 · Helen E. White, Matthew Salmon, et al. · Leukemia · 39
The effect of β-carotene and its derivatives on cytotoxicity, differentiation, proliferative potential and apoptosis on the three human acute leukemia cell lines: U-937, HL-60 and TF-1
2005 · Tomasz Sacha, Magdalena Zawada, et al. · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · 26
PDF
Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy
2022 · Matthew Salmon, Helen E. White, et al. · Leukemia · 22
PDF
Wilms' tumor gene 1 expression analysis by real-time quantitative polymerase chain reaction for monitoring of minimal residual disease in acute leukemia
2009 · Alicja Nowakowska-Kopera, Tomasz Sacha, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 22
Pax7 as molecular switch regulating early and advanced stages of myogenic mouse ESC differentiation in teratomas
2020 · Anita Florkowska, Igor Meszka, et al. · Stem Cell Research & Therapy · 20
PDF
IDH2 mutations in patients with normal karyotype AML predict favorable responses to daunorubicin, cytarabine and cladribine regimen
2021 · Marta Libura, Emilia Bialopiotrowicz, et al. · Scientific Reports · 13
Long-term outcomes of patients with Chronic Myeloid Leukemia who commenced treatment with imatinib: a 20-year single-centre experience
2022 · Elżbieta Szczepanek, Ositadima Chukwu, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 12
Serum Insights: Leveraging the Power of miRNA Profiling as an Early Diagnostic Tool for Non-Small Cell Lung Cancer
2023 · Radoslaw Charkiewicz, Anetta Sulewska, et al. · Cancers · 11
PDF
The Microarray Expression Analysis Identifies BAX as a Mediator of β-Carotene Effects on Apoptosis
2005 · Marek Bodzioch, Aldona Dembinska-Kiec, et al. · Nutrition and Cancer · 11
High Level of CD8+PD-1+ Cells in Patients with Chronic Myeloid Leukemia Who Experienced Loss of MMR after Imatinib Discontinuation
2024 · Paulina Kwaśnik, Joanna Zaleska, et al. · Cells · 7
PDF
PAX7 Balances the Cell Cycle Progression via Regulating Expression of Dnmt3b and Apobec2 in Differentiating PSCs
2021 · Anita Florkowska, Igor Meszka, et al. · Cells · 7
PDF
The Role of Single Nucleotide Polymorphisms of Monoamine Oxidase B, Dopamine D2 Receptor, and DOPA Decarboxylase Receptors Among Patients Treated for Parkinson’s Disease
2022 · Barbara Zapała, Tomasz Stefura, et al. · Journal of Molecular Neuroscience · 6
[Standardization of quantitative detection of BCR-ABL gene expression by RQ-PCR in patients with chronic myeloid leukemia in cooperation with European Leukemia Net].
2010 · Tomasz Sacha, Magdalena Zawada, et al. · PubMed · 6
ASXL1 Mutations Detectable at Diagnosis May Predict Response to Imatinib in Patients with Chronic Myeloid Leukemia
2019 · Marcin M Machnicki, Monika Pepek, et al. · Blood · 5
[Beta-carotene regulates the expression of proapoptotic BAX and CAPN2 in HL-60, U-937 and TF-1 - human acute myeloid leukemia cell lines; microarray, RQ-PCR and Western Blot analysis].
2011 · Tomasz Sacha, Magdalena Zawada, et al. · PubMed · 4
Prognostic Impact of Copy Number Alterations’ Profile and AID/RAG Signatures in Acute Lymphoblastic Leukemia (ALL) with BCR::ABL and without Recurrent Genetic Aberrations (NEG ALL) Treated with Intensive Chemotherapy
2023 · Marta Libura, Karolina Karabin, et al. · Cancers · 3
PDF
Comparison of ABL1 and Gusb Reference Genes in the qRT-PCR Analysis of Halving Time and Early Molecular Response to TKI Therapy in Patients with Chronic Myeloid Leukemia
2016 · Joanna Wącław, Magdalena Zawada, et al. · Blood · 3
CEBPA copy number variations in normal karyotype acute myeloid leukemia: Possible role of breakpoint-associated microhomology and chromatin status in CEBPA mutagenesis
2015 · Marta Libura, Marta Pawełczyk, et al. · Blood Cells Molecules and Diseases · 3
[Atypical BCR-ABL transcripts in patients with chronic myeloid leukemia--the scheme for the diagnosis and monitoring of minimal residual disease].
2014 · Dorota Link-Lenczowska, Tomasz Sacha, et al. · PubMed · 3
[Evaluation of hematopoietic chimerism after allogeneic bone marrow transplantation by modern molecular techniques (STR-PCR and RQ-PCR)--single center].
2010 · Sylwia Czekalska, Tomasz Sacha, et al. · PubMed · 3
Prognostic Factors in Treatment of Chronic Myeloid Leukemia with Tyrosine Kinase Inhibitors- Single Center Experience.
2009 · Kajetana Foryciarz, Tomasz Sacha, et al. · Blood · 3
Long-Term Outcomes of Imatinib Real-Life Treatment for Chronic Myeloid Leukemia- a 20-Year Review
2020 · Elzbieta Szczepanek, Ositadima Chukwu, et al. · Blood · 2
Monitorowanie kinetyki zmian wczesnego chimeryzmu hematopoetycznego i charakterystyka wszczepienia molekularnego za pomocą metody STR-PCR u pacjentów poddanych alloHSCT
2012 · Sylwia Czekalska, Beata Piątkowska-Jakubas, et al. · Acta Haematologica Polonica · 2
Works count: 56
Citation count: 341
H-index: 11
I10-index: 11
Year
Topic
Type